日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a Prophylactic mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome Using HSA based LNP

利用基于HSA的脂质纳米颗粒开发用于治疗发热伴血小板减少综合征的预防性mRNA疫苗

Ganbold, Tsenddari; Lkhagva, Enkhchimeg; Munkhtur, Enkhtsatsral; Acharya, Satabdi; Kim, Hyeon Jin; Hong, Seong-Tschool

Advancements in vaccine development and therapeutic approaches for severe fever with Thrombocytopenia Syndrome

血小板减少性发热综合征疫苗研发和治疗方法的进展

Ganbold, Tsenddari; Acharya, Satabdi; Sheet, Sunirmal; Munkhtur, Enkhtsatsral; Hong, Seong-Tshool

Protocol to generate a microfluidic vessels-on-chip platform using human pluripotent stem cell-derived endothelial cells

使用人类多能干细胞衍生的内皮细胞生成微流体芯片血管平台的协议

Caroline Remmert, Munkhtur Otgonbayar, Julius Alexander Perschel, Maren Marder, Matthias Meier

ROS mediated anticandidal efficacy of 3-Bromopyruvate prevents vulvovaginal candidiasis in mice model

3-溴丙酮酸通过ROS介导的抗念珠菌功效可预防小鼠外阴阴道念珠菌病模型

Jothi, Ravi; Hong, Seong-Tshool; Enkhtsatsral, Munkhtur; Pandian, Shunmugiah Karutha; Gowrishankar, Shanmugaraj